This Experimental Treatment Cut Cholesterol by 62 Percent—With No Statins
RSS SUMMARY · AGGREGATED FROM INC
A study published in the New England Journal of Medicine revealed a new therapy that can cut “bad” cholesterol by 62 percent with one dose. Could it replace lifelong statin use?
A study published in the New England Journal of Medicine revealed a new therapy that can cut “bad” cholesterol by 62 percent with one dose. Could it replace lifelong statin use?
A study published in the New England Journal of Medicine revealed a new therapy that can cut “bad” cholesterol by 62 percent with one dose. Could it replace lifelong statin use?
Continue Reading
The full story continues on Inc..
Story Sentry shows a short summary aggregated via RSS. The complete article — original photography, charts, and reporting — lives with the publisher.
The Source
INC
Business
Kane Footwear Is Growing Fast. One Simple Design Choice Is Powering Its Recovery Shoe Success
INC·1h ago·3 min read
Business
They Tracked Followers and Traffic for Years. Now, These 4 Founders Say Those Metrics Are a Waste of Time
INC·2h ago·3 min read
Business
How to Destroy a Successful Company
INC·2h ago·3 min read
Business
The 5 Vital Numbers You Must Put in Your Next LinkedIn Funding Announcement
INC·2h ago·3 min read
Related
On this beat
Business
Why institutional investors are returning to retail ‘in a very big way’
CNBC·47m ago·3 min read
Business
Inside Wealth: Trump’s ‘big beautiful bill’ has a ‘double taxation’ trap for top earners, tax lawyers say
CNBC·53m ago·3 min read
Business
6 shoe trends that are in this summer and 3 that are out, according to stylists
BI·50m ago·3 min read
Business
How to secure your child’s financial future with a special needs trust
THE STREET·1h ago·3 min read